Human Trials for Potential Vaccine Begin

Part of a worldwide scramble.

Pfizer and the German company BioNTech announced Tuesday that they have begun human trials on a potential vaccine against the coronavirus. The first stage will include up to 360 people, and involve testing measures like whether the vaccine is safe and what the proper dosage level is.

The move is part of what is seen as a worldwide scramble to try to get a vaccine for the highly infectious disease quicker than has ever been done before.

Pfizer and BioNTech are actually testing four vaccine possibilities at the same time—all different versions of what is known as an mRNA vaccine. The companies hope testing all four will allow the process to move more quickly by seeing which one works best.

“We are optimistic that advancing multiple vaccine candidates into human trials will allow us to identify the safest, most effective vaccination options against COVID-19,” said BioNTech CEO Ugur Sahin.

As the Lord Leads, Pray with Us…

  • That one of the vaccines being tested by these companies and others around the globe will prove to be highly successful and easy to produce quickly and in vast quantities
  • About the continuing spread of the coronavirus and the increases in deaths being seen this week.

Sources: The Hill, Reuters


Back to top